Key Financial Data Of Reporting Company

Fuji Pharma Co.,Ltd. - Filing #7712320

Concept 2019-01-01 to
2019-03-31
2018-10-01 to
2019-03-31
As at
2019-03-31
As at
2018-09-30
2017-10-01 to
2018-09-30
As at
2018-03-31
2018-01-01 to
2018-03-31
2017-10-01 to
2018-03-31
Key financial data of reporting company
Business results of reporting company
Net sales
18,483,000,000 JPY
37,909,000,000 JPY
17,961,000,000 JPY
Ordinary profit (loss)
2,501,000,000 JPY
4,472,000,000 JPY
2,360,000,000 JPY
Net assets
36,754,000,000 JPY
35,350,000,000 JPY
33,929,000,000 JPY
Total assets
59,013,000,000 JPY
53,117,000,000 JPY
49,848,000,000 JPY
Basic earnings (loss) per share
20.03
56.66
112.68
14.77
58.24
Diluted earnings per share
Equity-to-asset ratio
0.623 xbrli:pure
0.665 xbrli:pure
0.681 xbrli:pure
Net cash provided by (used in) operating activities
2,281,000,000 JPY
3,773,000,000 JPY
1,702,000,000 JPY
Net cash provided by (used in) investing activities
-8,150,000,000 JPY
-1,073,000,000 JPY
-233,000,000 JPY
Net cash provided by (used in) financing activities
6,068,000,000 JPY
-2,001,000,000 JPY
-1,332,000,000 JPY
Cash and cash equivalents
6,435,000,000 JPY
6,251,000,000 JPY
5,624,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.